OTC · ETBI
Eastgate Biotech Corp.
$0.01$0.00 (0.0%)
Eastgate Biotech Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
Loading market information…
OTC · QRON · USD
Stock price, earnings
Quote as of May 27, 2026, 01:30 PM UTC. Cached market data; not a live quote.
One-year closing-price history · USD. Historical prices are not a forecast.
Qrons Inc.’s quoted price sits in the lower half of its reported 52-week range, 93.58% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow Qrons Inc.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
Qrons, Inc. is a biotechnology company, which engages in the development of treatments and technologies for neuronal and infectious diseases. Its proprietary patents include Techniques for Promoting Neuronal Recovery, Therapeutic Polypseudorotaxane Hydrogels, and Tellurium Compositions and Techniques for Use Therewith. The company was founded by Jonah Martin Meer and Ido Merfeld on August 22, 2016 and is headquartered in Glendale, CA.
Latest available per-share figures in USD. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 07:54 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$0.01$0.00 (0.0%)
Eastgate Biotech Corp.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Aoxing Pharmaceutical Company, Inc.’s quoted price sits in the lower half of its reported 52-week range, 69.33% below the high.
$0.00$0.00 (0.0%)
CBD Life Sciences Inc.’s quoted price sits in the lower half of its reported 52-week range, 60.0% below the high.
$0.00$0.00 (0.0%)
BioSyntech, Inc.’s quoted price sits in the upper half of its reported 52-week range, 0.0% below the high.
$0.00$0.00 (0.0%)
Link Reservations Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
Bioasis Technologies Inc.’s quoted price sits in the lower half of its reported 52-week range, 50.0% below the high.
$0.00$0.00 (0.0%)
Hemagen Diagnostics, Inc.’s quoted price sits in the lower half of its reported 52-week range, 99.84% below the high.
$0.00$0.00 (0.0%)
Regnum Corp.: Communication Services · Entertainment.
